US2002182274A1PendingUtilityA1
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
Priority: Mar 21, 2001Filed: Mar 21, 2001Published: Dec 5, 2002
Est. expiryMar 21, 2021(expired)· nominal 20-yr term from priority
Inventors:Kung-Ming Lu
A61P 37/08A61P 37/02A61P 43/00A61P 9/14A61P 9/04A61P 37/00A61P 9/10A61P 31/04A61P 29/00A61P 35/00A61P 31/00A61K 36/48A61P 1/04A61P 17/00A61P 11/06
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the preparation of therapeutic compositions comprising of fermented soy extracts made with lactic acid bacteria and the optional addition of at least a yeast. The invention also relates to therapeutic uses of such extracts in promoting general health, improving the health of subjects, preventing and/or treating cancer, preventing infections, reducing the incidence of infections, treating infections, treating asthma, treating inflammation, modulating the immune system and treating immune disorders.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for preventing or treating a disease or health disorder in a subject comprising administering an effective amount of a fermented soy extract to the subject in need of the prevention or treatment, wherein the fermented soy extract is made with the fermentation of an aqueous soy extract with at least one lactic acid bacteria.
2 . The method of claim 1 , wherein said disease or health disorder is a cancer and wherein the fermented soy extract inhibits the growth of the cancer.
3 . The method of claim 2 , wherein said cancer is breast cancer, prostrate cancer, leukemia, colon cancer, uterine cancer, ovarian cancer, endometrial cancer, cervical cancer, colon cancer, testicular cancer, lymphoma, rhabdosarcoma, neuroblastoma, pancreatic cancer, lung cancer, brain tumor, skin cancer, gastric cancer, liver cancer, kidney cancer or nasopharyngeal carcinoma.
4 . The method of claim 3 , wherein said cancer is breast cancer.
5 . The method of claim 1 , wherein said disease or health disorder is an infection by a microbe and wherein the fermented soy extract inhibits the growth of the microbe.
6 . The method of claim 5 , wherein the microbe is a bacteria.
7 . The method of claim 5 , wherein the microbe is a fungus.
8 . The method of claim 1 , wherein said disease or health disorder is asthma and wherein the fermented soy extract is effective in preventing or treating asthmatic attacks.
9 . The method of claim 8 , wherein the fermented soy extract is effective in preventing or treating the asthmatic attacks by inhibiting lipooxygenase.
10 . The method of claim 9 , wherein the lipooxygenase is LOX-5, LOX-12 or LOX-15.
11 . The method of claim 1 , wherein said disease or health disorder is an immune disorder, and wherein the fermented soy extract is effective in preventing or treating the immune disorder.
12 . The method of claim 11 , wherein the fermented soy extract is effective in preventing or treating the immune disorder by inhibiting lipooxygenase.
13 . The method of claim 12 , wherein the lipooxygenase is LOX-5, LOX-12 or LOX-15.
14 . The method of claim 1 , wherein the disease or health disorder is inflammation, coronary heart disease, cardiac failure, allergy, ulcerative colitis, dermatitis or pruritis.
15 . The method of claim 14 , wherein the fermented soy extract is effective in preventing or treating the disease or health disorder by inhibiting lipooxygenase.
16 . The method of claim 15 , wherein the lipooxygenase is LOX-5, LOX-12 or LOX-15.
17 . A method of modulating the immunity of a subject, comprising administering an effective amount of a fermented soy extract to the subject in need ofthe immunomodulation, wherein the fermented soy extract is made with the fermentation of an aqueous soy extract with at least one lactic acid bacteria and wherein the fermented soy extract is effective in inhibiting lipooxygenase.
18 . The method of claim 17 , wherein the lipooxygenase is LOX-5, LOX-12 or LOX-15.
19 . A method of inhibiting lipooxygenase in a subject, comprising administering an effective amount of a fermented soy extract to the subject in need of thereof, wherein the fermented soy extract is made with the fermentation of an aqueous soy extract with at least one lactic acid bacteria.
20 . The method of claim 19 , wherein the lipooxygenase is LOX-5, LOX-12 or LOX-15.
21 . The method of claim 1 , wherein the fermentation of the aqueous soy extract is conducted with at least one lactic acid bacteria and a yeast, wherein the lactic acid bacteria is a Lactobacillus species.Join the waitlist — get patent alerts
Track US2002182274A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.